| NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, S Bean, K Bradley, SM Campos, HS Chon, ... Journal of the National Comprehensive Cancer Network 18 (6), 660-666, 2020 | 275 | 2020 |
| Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis R Vargas, JA Rauh-Hain, J Clemmer, RM Clark, A Goodman, ... Gynecologic oncology 133 (2), 216-220, 2014 | 203 | 2014 |
| Advances in suture material for obstetric and gynecologic surgery JA Greenberg, RM Clark Reviews in Obstetrics and Gynecology 2 (3), 146, 2009 | 180 | 2009 |
| MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls A Kilcoyne, AS Shenoy-Bhangle, DJ Roberts, RC Sisodia, DA Gervais, ... American Journal of Roentgenology 208 (1), 214-221, 2017 | 164 | 2017 |
| Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology N Abu-Rustum, C Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (2), 181-209, 2023 | 150 | 2023 |
| NCCN Guidelines® insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, K Bradley, SM Campos, J Chino, HS Chon, ... Journal of the National Comprehensive Cancer Network 19 (8), 888-895, 2021 | 129 | 2021 |
| Uterine carcinosarcomas: incidence and trends in management and survival CD Arrastia, RG Fruchter, M Clark, M Maiman, JC Remy, M Macasaet, ... Gynecologic oncology 65 (1), 158-163, 1997 | 128 | 1997 |
| Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology NR Abu-Rustum, CM Yashar, S Bean, K Bradley, SM Campos, HS Chon, ... Journal of the National Comprehensive Cancer Network 17 (11), 1374-1391, 2019 | 119 | 2019 |
| Laparoscopy compared with laparotomy for debulking ovarian cancer after neoadjuvant chemotherapy A Melamed, R Nitecki, DM Boruta, MG Del Carmen, RM Clark, ... Obstetrics & Gynecology 129 (5), 861-869, 2017 | 73 | 2017 |
| Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer N Joseph, RM Clark, DS Dizon, MS Lee, A Goodman, D Boruta Jr, ... Gynecologic oncology 137 (3), 401-405, 2015 | 73 | 2015 |
| Racial disparities in cervical cancer survival over time JA Rauh‐Hain, JT Clemmer, LS Bradford, RM Clark, WB Growdon, ... Cancer 119 (20), 3644-3652, 2013 | 73 | 2013 |
| Factors associated with increased collection of patient-reported outcomes within a large health care system RC Sisodia, C Dankers, J Orav, B Joseph, P Meyers, P Wright, DS Amand, ... JAMA Network Open 3 (4), e202764-e202764, 2020 | 68 | 2020 |
| Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis JA Rauh-Hain, EJ Diver, JT Clemmer, LS Bradford, RM Clark, ... Gynecologic oncology 131 (1), 46-51, 2013 | 68 | 2013 |
| The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. RM Clark, NS Nevadunsky, S Ghosh, DP Goldstein, RS Berkowitz The Journal of reproductive medicine 55 (5-6), 194-198, 2010 | 67 | 2010 |
| Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma RM Clark, WB Growdon, A Wiechert, D Boruta, M Del Carmen, ... Gynecologic oncology 130 (3), 407-410, 2013 | 51 | 2013 |
| Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis R Nitecki, EJ Diver, MM Kamdar, DM Boruta II, MC Del Carmen, RM Clark, ... Gynecologic oncology 148 (3), 521-526, 2018 | 49 | 2018 |
| Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter? JO Schorge, RM Clark, SI Lee, RT Penson Gynecologic oncology 135 (3), 595-605, 2014 | 49 | 2014 |
| Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer LS Bradford, A Rauh-Hain, RM Clark, JW Groeneweg, L Zhang, D Borger, ... Gynecologic oncology 133 (2), 346-352, 2014 | 42 | 2014 |
| The surgeon's perceived value of patient-reported outcome measures (PROMs): an exploratory qualitative study of 5 different surgical subspecialties D Mou, RC Sisodia, M Castillo-Angeles, K Ladin, RW Bergmark, AL Pusic, ... Annals of surgery 275 (3), 500-505, 2022 | 41 | 2022 |
| Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy RM Clark, MS Lee, JA Rauh‐Hain, T Hall, DM Boruta, MG Del Carmen, ... Gynecologic oncology 136 (3), 516-520, 2015 | 41 | 2015 |
Annekathryn GoodmanProfessor Obstetrics, Gynecology, Reproductive Biology Harvard Medical Scholl在 mgh.harvard.edu 的电子邮件经过验证
